Dr. Now Hires Executives from Coupang and Baemin: "We Will Build a Medical Super App"

Dr. Now announced on the 5th that it has recruited CTO Hyunseok Lee, formerly of Coupang and Kakao, and CMO Youngmo Ahn, formerly of Nexon and Baedal Minjok. From the left in the photo are CTO Lee and CMO Ahn. [Photo by Dr. Now]

[Asia Economy Reporter Junhyung Lee] Remote medical platform DoctorNow has consecutively recruited platform business experts as executives.

On the 5th, DoctorNow announced that it had hired CTO Hyunseok Lee, formerly of Coupang and Kakao, and CMO Youngmo Ahn, formerly of Nexon and Baedal Minjok. This is interpreted as a strategic move toward the company's goal this year of making "non-face-to-face medical treatment and medicine delivery a national service." Additionally, the company will accelerate the construction of a "medical super app" starting with this executive recruitment. A super app is an application that gathers various services into a single platform.

New CTO Lee is a veteran engineer who designed order and delivery systems optimized for user experience at Coupang and Kakao Style. CTO Lee is expected to focus on strengthening DoctorNow’s platform service functions and enhancing user convenience. He said, "We aim to achieve technological advancement that encompasses healthcare overall, including non-face-to-face medical treatment," adding, "As top talents are joining the company, we will develop services that prioritize customers above all."

New CMO Ahn is a marketing expert with experience at Nexon, Baedal Minjok, and Blank Corporation. He is recognized for increasing user inflow through performance-driven content marketing across various online channels. CMO Ahn stated, "Awareness and customer experience expansion for non-face-to-face medical treatment are just beginning," and added, "We will grow DoctorNow into a service used by half the nation within this year."

DoctorNow is a startup that emerged after non-face-to-face medical treatment was temporarily permitted in 2020 due to COVID-19. In December 2020, it launched Korea’s first non-face-to-face medical treatment and prescription drug delivery service. Within one year of service launch, it surpassed 600,000 cumulative downloads and 900,000 cumulative users. In October last year, it secured 10 billion KRW in Series A funding from SoftBank Ventures and Saehan Startup Investment, among others.

Along with the new executives, the company additionally recruited Product Owner Haneul Jang, formerly of Wemade and Npixel, and Sales Director Taehwan Kim, formerly of Johnson & Johnson and Kolmar Korea. The company is also focusing on recruiting developers and other talents. Recently, it announced improved compensation, including up to a 1.5-fold salary increase for developers, stock options worth up to 100 million KRW, and an immediate signing bonus of 10 million KRW upon hiring. It also provides rewards to internal and external personnel who recommend talents.

This content was produced with the assistance of AI translation services.